Insmed Incorporated · 1 day ago
Summer Intern - Mass Spectrometry
Joint Training and Training Development Center, NJ
Internship
Onsite
Intern
$20/hr - $35/hr
Start in 2026 SummerInsmed Incorporated is a global biopharmaceutical company dedicated to transforming the lives of patients with serious and rare diseases. The Summer Internship Program offers students hands-on experience in the pharmaceutical industry, where they will conduct analysis of small molecules and support various pipeline projects in the Research Department.
BiotechnologyMedicalPharmaceutical
Responsibilities
Perform routine sample extraction
Sample analysis by LC-MS/MS
Generate result summary table
Maintain proper Electric Notebook (ELN) to capture all experiment detail
Qualification
Required
You are a current student working on a Bachelor's, Master's, or advanced level degree in Chemistry, Pharmaceutical Science or related discipline
Interested in pursuing a career in the pharmaceutical industry
Must have excellent communication skills (verbal and written)
Highly organized with a strong attention to detail, clarity, accuracy and conciseness
Highly proficient in Microsoft Office (Word, Excel, PowerPoint, Outlook)
Benefits
Paid company holidays
Hands-on learning in real-world projects
Networking opportunities with leaders and social events with your peers
Mentorship and professional development
A final presentation to celebrate your contributions
Access to office amenities for those who are not remote
Company
Insmed Incorporated
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
Founded in 1988
1001-5000 employees
H1B Sponsorship
Insmed Incorporated has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (20)
2024 (6)
2023 (14)
2022 (8)
2021 (1)
2020 (5)
Funding
Current Stage
Public CompanyTotal Funding
$4.56BKey Investors
CureDuchenne Ventures
2025-06-11Post Ipo Equity· $750M
2024-05-30Post Ipo Equity· $650M
2023-05-08Post Ipo Equity· $0.5M
Leadership Team
Will Lewis
Chairman and Chief Executive officer
Walter R. Perkins
Chief Technology Officer
Recent News
2026-01-03
Company data provided by crunchbase